BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,217,394 | +42.9% | 14,404,000 | 0.0% | 0.45% | +40.7% |
| Q2 2023 | $11,346,287 | +6.3% | 14,404,000 | 0.0% | 0.32% | +8.2% |
| Q1 2023 | $10,673,364 | +62.3% | 14,404,000 | -1.4% | 0.29% | +74.4% |
| Q4 2022 | $6,574,950 | -24.8% | 14,611,000 | 0.0% | 0.17% | -24.0% |
| Q3 2022 | $8,749,000 | +8.1% | 14,611,000 | 0.0% | 0.22% | +12.8% |
| Q2 2022 | $8,091,000 | -5.2% | 14,611,000 | 0.0% | 0.20% | +161.3% |
| Q1 2022 | $8,533,000 | -20.8% | 14,611,000 | 0.0% | 0.08% | -15.7% |
| Q4 2021 | $10,771,000 | -46.7% | 14,611,000 | 0.0% | 0.09% | -53.2% |
| Q3 2021 | $20,195,000 | -16.0% | 14,611,000 | 0.0% | 0.19% | -15.9% |
| Q2 2021 | $24,035,000 | +20.3% | 14,611,000 | +21.0% | 0.23% | +54.8% |
| Q1 2021 | $19,978,000 | – | 12,076,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 141,500,000 | $63,675,000 | 2.13% |
| ARISTEIA CAPITAL, L.L.C. | 156,841,000 | $70,578,450 | 1.41% |
| Affinity Asset Advisors, LLC | 7,500,000 | $3,410,048 | 1.34% |
| CONTRARIAN CAPITAL MANAGEMENT, L.L.C. | 8,500,000 | $3,782,500 | 0.94% |
| TFG Asset Management GP Ltd | 10,000,000 | $4,623,611 | 0.66% |
| Context Capital Management, LLC | 17,035 | $7,890 | 0.58% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 47,329,000 | $18,813 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $2,287,850 | 0.32% |
| MACKAY SHIELDS LLC | 14,611,000 | $6,574,950 | 0.17% |
| Ionic Capital Management LLC | 1,400,000 | $644,740 | 0.15% |